Abstract
Chronic rhinosinusitis is a heterogeneous group of chronic sinus diseases that may consist of clearly different disease entities. Further investigation of the pathomechanisms of chronic rhinosinusitis and the introduction of appropriate disease markers have recently facilitated disease classification. Evaluation of inflammatory cell profiles, the differentiation of T-effector cells, characterization of remodeling processes such as fibrosis or edema formation, and innate or adaptive immunity products such as Toll-like receptors and immunoglobulins all provide tools to identify distinct disease entities within the group of chronic sinus diseases. This disease differentiation will not only increase our knowledge of the pathophysiology of sinusitis but may lead to new diagnostic and therapeutic strategies specifically targeted and adapted to the diagnosed disease entity.
Similar content being viewed by others
References and Recommended Reading
Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S: The health and productivity cost burden of the “top 10” physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003, 45:5–14.
Ray NF, Baraniuk JN, Thamer M, et al.: Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999, 103:408–414.
Durr DG, Desrosiers MY, Dassa C: Impact of rhinosinusitis in health care delivery: the Quebec experience. J Otolaryngol 2001, 30:93–97.
Gwaltney J: Microbiology of sinusitis. In Sinusitis: Pathophysiology and Treatment. Edited by Druce HM. New York: Marcel Dekker; 1994:41–56.
Baraniuk J: Physiology of sinusitis. In Sinusitis: Pathophysiology and Treatment. Edited by Druce HM. New York: Marcel Dekker; 1994:19–40.
Stammberger H: Endoscopic endonasal surgery-concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg 1986, 94:143–147.
Collins JG: Prevalence of selected chronic conditions: United States, 1990–1992. Vital Health Stat 10 1997, Jan:1–89.
Benninger MS: Rhinitis, sinusitis, and their relationships to allergies. Am J Rhinol 1992, 6:37–43.
Ratjen F, Doring G: Cystic fibrosis. Lancet 2003, 361:681–689.
Schubert MS: Allergic fungal sinusitis. Otolaryngol Clin North Am 2004, 37:301–326.
Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147–S334.
Hens G, Vanaudenaerde BM, Bullens DM, et al.: Sinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergy. Allergy 2008, 63:261–267.
Miles-Lawrence R, Kaplan M, Chang K: Methacholine sensitivity in nasal polyposis and the effects of polypectomy [abstract]. J Allergy Clin Immunol 1982, 69:102.
Blackwell DL, Collins JG, Coles R: Summary health statistics for U.S. adults: National Health Interview Survey, 1997. Vital Health Stat 10 2002, May:1–109.
Chen Y, Dales R, Lin M: The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003, 113:1199–1205.
Gordts F, Clement PA, Buisseret T: Prevalence of sinusitis signs in a non-ENT population. ORL J Otorhinolaryngol Relat Spec 1996, 58:315–319.
Hosemann W, Gode U, Wagner W: Epidemiology, pathophysiology of nasal polyposis, and spectrum of endonasal sinus surgery. Am J Otolaryngol 1994, 15:85–98.
Hedman J, Kaprio J, Poussa T, Nieminen MM: Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717–722.
Moloney JR: Nasal polyps, nasal polypectomy, asthma, and aspirin sensitivity. Their association in 445 cases of nasal polyps. J Laryngol Otol 1977, 91:837–846.
Meltzer EO, Hamilos DL, Hadley JA, et al.: Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004, 131:S1–S62.
Uffredi ML, Mangiapan G, Cadranel J, Kac G: Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients. Eur J Clin Microbiol Infect Dis 2003, 22:457–462.
Ebbens FA, Scadding GK, Badia L, et al.: Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149–1156.
Gysin C, Alothman GA, Papsin BC: Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol 2000, 30:481–489.
Coste A, Idrissi F, Beautru R, et al.: [Endoscopic endonasal ethmoidectomy in severe sinusitis of cystic fibrosis. Mid-term results in 12 patients]. Ann Otolaryngol Chir Cervicofac 1997, 114:99–104.
Jones JW, Parsons DS, Cuyler JP: The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis. Int J Pediatr Otorhinolaryngol 1993, 28:25–32.
Van Zele T, Claeys S, Gevaert P, et al.: Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006, 61:1280–1289.
Bachert C, Gevaert P, Holtappels G, et al.: Nasal polyposis: from cytokines to growth. Am J Rhinol 2000, 14:279–290.
Van Zele T, Gevaert P, Watelet JB, et al.: Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004, 114:981–983.
Bachert C, Gevaert P, Holtappels G, et al.: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001, 107:607–614.
Claeys S, Van Hoecke H, Holtappels G, et al.: Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005, 35:467–472.
Muhlebach MS, Stewart PW, Leigh MW, Noah TL: Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999, 160:186–191.
Van Bruaene N, Perez-Novo CA, Basinski TM, et al.: T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008, 121:1435–1441.
Zhang N, Van Zele T, Perez-Novo C, et al.: Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008, 122:961–968.
Van Bruaene N, Derycke L, Perez-Novo CA, et al.: TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009 (in press).
Watelet JB, Bachert C, Claeys C, Van Cauwenberge P: Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004, 59:54–60.
Kostamo K, Tervahartiala T, Sorsa T, et al.: Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 2007, 117:638–643.
Lechapt-Zalcman E, Coste A, d’Ortho MP, et al.: Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001, 193:233–241.
Chen YS, Langhammer T, Westhofen M, Lorenzen J: Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy 2007, 62:66–72.
Bachert C, Zhang N, Patou J, et al.: Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 2008, 8:34–38.
Tripathi A, Kern R, Conley DB, et al.: Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol 2005, 19:327–333.
Patou J, Gevaert P, Van Zele T, et al.: Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008, 121:110–115.
Van Zele T, Gevaert P, Holtappels G, et al.: Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007, 37:1840–1847.
Keith PK, Conway M, Evans S, et al.: Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol 1994, 93:567–574.
Leung DY, Harbeck R, Bina P, et al.: Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993, 92:1374–1380.
Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group: EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007, 45:97–101.
Corey JJP, Bumsted RRM: Revision endoscopic ethmoidectomy for chronic rhinosinusitis. Otolaryngol Clin North Am 1989, 22:801–808.
Moses RL, Cornetta A, Atkins JP Jr, et al.: Revision endoscopic sinus surgery: the Thomas Jefferson University experience. Ear Nose Throat J 1998, 77:190.
Senior BA, Kennedy DW, Tanabodee J, et al.: Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998, 108:151–157.
Watelet JB, Claeys C, Van Cauwenberge P, Bachert C: Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Repair Regen 2004, 12:412–418.
Huvenne W, Zhang N, Tijsma E, et al.: Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen 2008, 16:757–767.
Gevaert P, Lang-Loidolt D, Lackner A, et al.: Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006, 118:1133–1141.
Gevaert P, Holtappels G, Johansson SG, et al.: Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005, 60:71–79.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huvenne, W., van Bruaene, N., Zhang, N. et al. Chronic rhinosinusitis with and without nasal polyps: What is the difference?. Curr Allergy Asthma Rep 9, 213–220 (2009). https://doi.org/10.1007/s11882-009-0031-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-009-0031-4